[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Indexing::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 6, Issue 2 (12-2022) ::
CRMS 2022, 6(2): 58-63 Back to browse issues page
Effect of pantoprazole on prevention of gastrointestinal bleeding in acute coronary syndrome patients with high risk of gastrointestinal bleeding
P Mohammadi , M Sedaghat * , Z Rashvandi
Department of Internal Medicine, School of Medicine, shahid Beheshti University of Medical Sciences, Tehran, Iran , Sedaghat@sbmu.ac.ir
Abstract:   (594 Views)
Background and Objective: Determination of best preventive approach for gastrointestinal bleeding in Acute Coronary Syndrome (ACS) patients with high risk of gastrointestinal bleeding is crucial. This study aimed to determine the effect of pantoprazole on prevention of gastrointestinal bleeding in ACS patients with high risk of gastrointestinal bleeding.
Methods: This randomized clinical trial was performed in emergency department of Imam Hussein Hospital in Tehran, Iran between 2018 and 2019 among 1276 consecutive ACS patients with high risk of gastrointestinal bleeding.The participants were randomly received either pantoprazole 40 mg or famotidine 40 mg daily. The melena, hematemesis, hematochezia, and hemoglobin level were compared across the groups after one month.
Findings: The results in this study demonstrated that melena was seen in 1.1% and 3.8% in pantoprazole and famotidine groups, respectively with significant difference (P=0.002). Hematemesis was seen in 0.6% and 1.9% in pantoprazole and famotidine groups, respectively with significant difference (P=0.044). Also, hematochezia was seen in 0.3% and 0.8% in pantoprazole and famotidine groups, respectively without significant difference (P=0.452). The mean hemoglobin was 11.98 and 11.82 in pantoprazole and famotidine groups, respectively with significant difference (P=0.021).
Conclusion: This study showed that pantoprazole (versus famotidine) is effective for prevention of gastrointestinal bleeding in Acute Coronary Syndrome patients with high risk of gastrointestinal bleeding.
Keywords: Pantoprazole, Gastrointestinal bleeding, Acute coronary syndrome
Full-Text [PDF 425 kb]   (488 Downloads)    
Type of Study: Original Article | Subject: داخلی
Received: 2022/12/7 | Accepted: 2022/12/25 | Published: 2023/01/28
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammadi P, Sedaghat M, Rashvandi Z. Effect of pantoprazole on prevention of gastrointestinal bleeding in acute coronary syndrome patients with high risk of gastrointestinal bleeding. CRMS 2022; 6 (2) :58-63
URL: http://crms.mubabol.ac.ir/article-1-129-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 6, Issue 2 (12-2022) Back to browse issues page
Current Research in Medical Sciences
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645